Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reducing risks in blood transfusion: process and outcome

D B McClelland1, J J McMenamin, H M Moores

  • 1Edinburgh South East Scotland Blood Transfusion Service, UK.

Transfusion Medicine (Oxford, England)
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detectable anti-proteinase-3 antibodies precede clinical manifestations in a case of anti-neutrophil cytoplasmic antibody-associated vasculitis.

Scandinavian journal of rheumatology·2020
Same author

The introduction of anti-HTLV testing of blood donations and the risk of transfusion-transmitted HTLV, UK: 2002-2006.

Transfusion medicine (Oxford, England)·2009
Same author

Acute effects of haemodialysis on biochemical modulators of endothelial function.

Journal of internal medicine·2007
Same author

Increase in recently acquired syphilis infections in English, Welsh and Northern Irish blood donors.

Vox sanguinis·2007
Same author

Prevalence of ischaemic heart disease at admission to intensive care and its influence on red cell transfusion thresholds: multicentre Scottish Study.

British journal of anaesthesia·2005
Same author

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

The Cochrane database of systematic reviews·2002
Same journal

First identification and molecular characterisation of a rare D- - donor in Saudi Arabia.

Transfusion medicine (Oxford, England)·2026
Same journal

Early Haemoglobin response after single-unit red blood cell transfusion predicts repeat transfusion in hospitalised adults: A prospective cohort study and clinical prediction model.

Transfusion medicine (Oxford, England)·2026
Same journal

Identification and protein modelling analysis of a homozygous FUT1*01W.09 variant in a Thai patient with the para-Bombay phenotype.

Transfusion medicine (Oxford, England)·2026
Same journal

Prioritising parameters to minimise blood transfusions for postpartum haemorrhage: A machine learning study using national population data.

Transfusion medicine (Oxford, England)·2026
Same journal

Implementation of BSH 2020 irradiation guidelines for children with DiGeorge syndrome.

Transfusion medicine (Oxford, England)·2026
Same journal

FAIRly deferred: Low impact of the individualised risk assessment policy on blood donor deferrals in England.

Transfusion medicine (Oxford, England)·2026
See all related articles

Significant advancements in blood safety have been achieved through improved donor screening and testing, reducing infection risks. However, challenges remain in the clinical transfusion process, emphasizing the need for better data sharing and standardized definitions for patient safety.

Area of Science:

  • Transfusion Medicine
  • Public Health
  • Infectious Disease Control

Background:

  • Substantial improvements in blood safety over the past decade have been driven by enhanced donor education, selection, testing, and exclusion.
  • Residual risks of transfusion-transmitted infections, such as Hepatitis B surface antigen (HBsAg) and Human Immunodeficiency Virus (HIV), have been significantly minimized.
  • Despite progress in laboratory safety, challenges persist in the clinical transfusion supply chain, including ensuring the right blood is administered to the right patient at the right time.

Purpose of the Study:

  • To highlight the progress in blood safety and identify remaining challenges in transfusion medicine.
  • To emphasize the need for standardized terminology and data sharing for national and international risk comparisons.
  • To advocate for evidence-based transfusion practices through the analysis of clinical outcomes.

Related Experiment Videos

Main Methods:

  • Review of advancements in donor screening, selection, testing, and exclusion processes.
  • Analysis of residual risks for transfusion-transmitted infections (HBsAg, HIV).
  • Identification of challenges in the clinical blood supply process and transfusion outcomes.

Main Results:

  • Laboratory errors contribute to a very low residual risk of HBsAg infection (<0.1/100,000), with HIV risk potentially approaching this level.
  • Statistical evidence for further risk reduction through incremental improvements in donor selection, testing, or exclusion is becoming difficult to obtain.
  • Less progress has been made in mitigating risks associated with the clinical supply process, such as logistical errors in blood delivery.

Conclusions:

  • Standardized definitions for blood donation characteristics and shared performance data are crucial for comparing transfusion risks nationally and internationally.
  • The use of agreed-upon definitions and sharing of clinical transfusion outcome data can lead to improved prescribing practices.
  • Focusing on the clinical supply chain and evidence-based outcomes is essential for enhancing overall patient safety in blood transfusions.